Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CellmAbs logo — A Leap Forward in Oncology

CellmAbs

A Leap Forward in Oncology

Founded 2019 Portugal Portugal 1 employees Seed Total: $3.20M Biotechnology

General Information

Company Name CellmAbs
Founded Year 2019
Location Portugal Portugal +1
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology
Funding Stage Seed
Social

Get notified when CellmAbs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CellmAbs

CellmAbs is a biotechnology startup founded in 2019, headquartered in Portugal, with a clear mission expressed in their slogan: "A Leap Forward in Oncology." The company is focused on researching and developing novel anti-cancer treatments. CellmAbs recently secured a $1.60M Seed Round investment on 13 November 2019, with participation from Portugal Ventures and Bionova Capital. This indicates growing investor confidence in the startup's potential to make significant strides in the field of oncology.

Taxonomy: Oncology, Biotech, Cancer treatment, Preclinical candidates, Glycan targets, CellmAbs, Research and development, Life Science, Venture Capital, Startup, NOVA University of Lisbon, Spin-off company, Portugal, Solid tumors, Investment

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
13 Nov 2019
Seed Round •••••• 2
Investor Investor
25 Jun 2019

FAQ About CellmAbs

A Leap Forward in Oncology
CellmAbs was founded in 2019.
CellmAbs is headquartered in Portugal.
CellmAbs operates in the following industries: Biotechnology.
CellmAbs has approximately 1 employees.
CellmAbs has completed 2 funding rounds, raising a total of $3.20M. The latest funding stage is Seed.

We're actively collecting intelligence on CellmAbs.

Track CellmAbs to get notified

Don't just browse. Track.

Signal Tracker monitors CellmAbs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy